Article

An AstraZeneca-FNRS-FWO Foundation award for Charlotte Beaudart

On 13 December 2023, Charlotte Beaudart, a new academic at the University of Namur Faculty of Medicine, will be awarded a prize at the annual ceremony for Belgian scientific research in support of her innovative research on the subject of ageing.
See content
Article

Yves Poumay, researcher on skin pathologies

As the largest and heaviest organ in the human body, the skin is the focus of Professor Yves Poumay's research. For nearly 30 years, within the Cells and Tissues laboratory (LabCeTi), he has been developing in vitro epidermal models that reproduce skin pathologies to better understand and treat them. A pioneering approach that offers alternatives to animal experimentation! On the eve of an international congress devoted to dermatology research organised at UNamur (see below), he talks about the importance of melanoma screening and details the latest advances in dermatology made in his laboratory.
See content
Event

Public thesis defense - Pauline TRICQUET

The Elongator complex is involved in the addition of 5'-carboxylmethyluridine (cm5U)-derived modifications to transfer RNAs (tRNAs), thereby influencing the translation of certain messenger RNAs (mRNAs) and helping to maintain the integrity of the proteome. This complex is involved in a variety of biological processes, and is of particular importance in oncology. The identification of chemical inhibitors of Elongator is of significant interest in both basic and pharmaceutical research.Through a yeast screen, this work reveals a potential new role for Elongator and identifies a chemical inhibitor of the complex. This compound presents itself as an interesting candidate as a pharmacological inhibitor, opening up new perspectives for the search for anti-cancer therapies.
See content
Article

A gift for labs in the Faculty of Science and Faculty of Medicine

In late November, the Mont-Saint-Guibert-based company Cellistic® donated equipment it no longer used to UNamur. By enabling the university to give this equipment a second life, Cellistic is making an important gesture in support of the development of university research.
See content
Article

Marc Hennequart, researcher at UNamur, receives a Grant from the Fondation contre le cancer (Cancer Foundation)

Since September 2023, Marc Hennequart, Professor of Biochemistry and Cell Biology at UNamur, has been conducting groundbreaking research into pancreatic cancer. His team, based at the Faculty of Medicine and the Institut Narilis, studies the early stages of oncogenesis (the process of transforming a normal cell into a cancerous one) to better understand the metabolic changes behind this particularly aggressive cancer.
See content
Article

Thomas Balligand: from Medicine to Fundamental Research at UNamur

Thomas Balligand, now a lecturer at UNamur, combines his passion for basic research with teaching in histology and cytology. After a diverse background in internal medicine and research, notably at Harvard, he is dedicated to training the next generation of scientists while pursuing his work on nanobodies and their potential in immunotherapy. His desire to awaken scientific curiosity in his students illuminates his new role at the university..
See content
Article

A new teaching unit at UNamur: "One Health

In an ever-changing world, where health, environmental and societal crises are intertwined, it is becoming imperative to rethink health in a global and interconnected approach. It was against this backdrop that the Faculty of Medicine at the University of Namur inaugurated its new "One Health" teaching unit (UE) on Thursday February 06, 2025, in the presence of Minister Yves Coppieters. This initiative, offered to all UNamur undergraduates, aims to train tomorrow's healthcare professionals in a systemic vision, where human, animal and environmental health are considered as one and the same reality.
See content
Event

Medical Journal Club in primary care

Target audienceGeneral practitioners (in practice or in training)PharmacistsMedical and pharmacy studentsObjectivesShare and discuss scientific articles relevant to frontline practice in a friendly and caring atmosphereStrengthen skills in critical reading and evidence-based medicineCreate a lasting link between the field and the academic worldFederate an active and committed medico-pharmaceutical community.pharmaceutical communityWhy participate?Because science moves fast, and we all benefit from taking the time to read, understand, and question the literature together. Because quality care starts with shared reflection. And because it's the ideal opportunity to strengthen bridges between disciplines.Location and frequency of meetingsUNamur - Quai22 - 2 times a yearFirst meeting: 5/06/2025 (free with registration)INAMI accreditation required. I want to register
See content
Article

Our researchers in the World's Top 2% Scientists list

Stanford University has published a prestigious ranking that highlights the most influential researchers in a wide range of scientific fields. The list, based on bibliographic criteria, aims to provide a standardized means of identifying the world's scientific leaders. It is one criterion among others for assessing the quality of scientific research. Twelve researchers from the University of Namur are among them!
See content
Article

Covid-19, five years on: A look back at UNamur's major role in the pandemic

The Covid-19 pandemic is a human tragedy that has caused millions of deaths worldwide and put our entire society under great strain. But it has also been a tremendous collective moment for many UNamur scientists, whose research continues in an attempt to better understand this disease and its consequences.
See content
Article

Facilitating the authorization of pediatric and orphan drugs

Bringing a new drug to market, particularly when it is intended to treat a pediatric or orphan disease, is a journey fraught with pitfalls. The ERAMET project, coordinated by Professor Flora Musuamba Tshinanu, aims to overhaul the assessment procedures, so that regulatory agencies can take innovative technologies into account and thus make more informed choices.
See content